Browse drugs

… regimens included ticagrelor (38.7%), clopidogrel (31.7%), and prasugrel (29.6%). At median 12-month follow-up, 97.8% of patients achiev…

…function], *17 [gain-of-function]) and VerifyNow PRU testing on clopidogrel. Thromboelastography with platelet mapping was available in 26.…

… (67.9%), clopidogrel (range 37.5-75 mg/day) in 33 (30.3%), and ticagrelor (range 90-180 mg/day) in 2 (1.8%) patients. Low-dose antiplatel…

…ic or haemorrhagic outcomes between the aspirin+clopidogrel and aspirin+ticagrelor regimens. However, the observed differences in survi…

…py (DAPT) with aspirin and ticagrelor for 3 months, followed by aspirin alone.Results A total of 24 patients with 25 aneurysms were inc…

…elor or prasugrel), to the control arm, bare p64-MW under DAPT (ticagrelor or prasugrel+aspirin), for unruptured IA management. The primar…

…treated IR injured hearts, especially DAPT with clopidogrel and ticagrelor. IR injury reduced ventricular perfusion and FCD neither of whi…

…irmed with carotid duplex. The patient was started on DAPT with aspirin, clopidogrel and subsequently underwent left ICA cervical segme…

…lications (TECs). Recently, newer-generation P2Y12 inhibitors - prasugrel and ticagrelor (PSG/TCG) - have emerged as potential alternativ…

… lower mortality at 6 months, 1 year, and 3 years compared with alteplase, without increased intracerebral hemorrhage. Early cognitive im…

… administration, and monitoring considerations are provided for aspirin, clopidogrel, prasugrel, ticagrelor, cangrelor, and glycoprotei…

…and a non-vitamin K antagonist OAC. In this patient population, clopidogrel is the P2Y12 inhibitor of choice given the significantly lower …